European Union
Government organization
Active
Brussels, Belgium
129
11M
120
4.16
11
0.06
10
- Areas of investment
Summary
European Union is the famous Corporate Investor, which was founded in 1951. The leading representative office of defined Corporate Investor is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.
The high activity for fund was in 2017. The usual things for fund are deals in the range of 5 - 10 millions dollars. Comparing to the other companies, this European Union performs on 25 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. Considering the real fund results, this Corporate Investor is 16 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the European Union, startups are often financed by Venture Kick, SOSV, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are Federal Ministry for Economic Affairs and Energy, Venture Kick, bmp Ventures. In the next rounds fund is usually obtained by Atlantic Labs, Omidyar Network, Horizon 2020.
We can highlight the next thriving fund investment areas, such as Health Care, Machine Learning. Among the most popular portfolio startups of the fund, we may highlight Quaero.org, Nuritas, SensArs. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Finland.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 129
- Lead investments
- 11
- Exits
- 10
- Rounds per year
- 4.16
- Follow on index
- 0.06
- Investments by industry
- Health Care (25)
- Artificial Intelligence (17)
- Medical Device (16)
- Information Technology (16)
- Biotechnology (14) Show 168 more
- Investments by region
-
- Germany (16)
- United States (11)
- France (6)
- Norway (1)
- South Korea (1) Show 34 more
- Peak activity year
- 2023
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.26
- Avg. company exit year
- 13
- Avg. multiplicator
- 0.00
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
forward earth | 18 Jun 2024 | Seed | 3M | Berlin, Berlin, Germany | |
Nanom | 02 Apr 2021 | Energy | Seed | 3M | United States, California, Palo Alto |
Imbria Pharmaceuticals | 01 Jul 2018 | Biotechnology, Health Care, Life Science, Pharmaceutical | Seed | United States, Massachusetts, Boston |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.